MediBIC Group

MediBIC Group provides healthcare platforms and drug development services. It offers genetic testing services for doctors, diagnostic tools; GLP-compliant genetic analysis services for pharmaceutical companies; sample banking and management services, and pet-focused healthcare services. The company is also involved in the development of cell culture systems; sales of consumables; promotion of licensing activities for the pancreatic cancer drug Glufosfamide; research and development of drugs and diagnostic agents; provision of data analysis for preventive care, and clinical trial services for cell therapy.